Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating

• Status: Terminated
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Sage tablets ( 3400 mg extract from fresh sage leaves, DER 1:17) in a once daily application over 12 treatment weeks are compared against placebo in 200 menopausal patients with ≥ 5 hot flushes daily and a Hyperhidrosis Scale score ≥ 2

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: A. Vogel AG; Bioforce AG

Criteria

Inclusion Criteria:

• Menopausal since ≥ 1 year

• ≥ 5 hot flushes /24 hours

• Hyperhidrosis Scale score ≥ 2

Exclusion Criteria:

• Affections like asthma, COPD, depression, diabetes, epilepsy, hyper- and hypothyreosis, malign tumours